T. Rowe Price Associates’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
256,654
+3,140
| +1% | +$15.6K | ﹤0.01% | 1861 |
|
|
2025
Q1 | $1.12M | Sell |
253,514
-1,678
| -0.7% | -$7.41K | ﹤0.01% | 1897 |
|
|
2024
Q4 | $1.19M | Buy |
255,192
+56,522
| +28% | +$263K | ﹤0.01% | 1887 |
|
|
2024
Q3 | $1.38M | Buy |
198,670
+180,370
| +986% | +$1.25M | ﹤0.01% | 1817 |
|
|
2024
Q2 | $143K | Buy |
18,300
+4,000
| +28% | +$31.3K | ﹤0.01% | 2677 |
|
|
2024
Q1 | $102K | Hold |
14,300
| – | – | ﹤0.01% | 2778 |
|
|
2023
Q4 | $96K | Hold |
14,300
| – | – | ﹤0.01% | 2720 |
|
|
2023
Q3 | $81K | Sell |
14,300
-4,700
| -25% | -$26.6K | ﹤0.01% | 2697 |
|
|
2023
Q2 | $105K | Hold |
19,000
| – | – | ﹤0.01% | 2689 |
|
|
2023
Q1 | $119K | Sell |
19,000
-6,100
| -24% | -$38.2K | ﹤0.01% | 2650 |
|
|
2022
Q4 | $117K | Hold |
25,100
| – | – | ﹤0.01% | 2682 |
|
|
2022
Q3 | $118K | Buy |
25,100
+1,000
| +4% | +$4.7K | ﹤0.01% | 2687 |
|
|
2022
Q2 | $143K | Buy |
24,100
+9,500
| +65% | +$56.4K | ﹤0.01% | 2673 |
|
|
2022
Q1 | $282K | Buy |
14,600
+5,300
| +57% | +$102K | ﹤0.01% | 2564 |
|
|
2021
Q4 | $304K | Sell |
9,300
-1,200
| -11% | -$39.2K | ﹤0.01% | 2587 |
|
|
2021
Q3 | $431K | Buy |
10,500
+3,600
| +52% | +$148K | ﹤0.01% | 2434 |
|
|
2021
Q2 | $248K | Sell |
6,900
-600
| -8% | -$21.6K | ﹤0.01% | 2639 |
|
|
2021
Q1 | $293K | Buy |
+7,500
| New | +$293K | ﹤0.01% | 2568 |
|
|
2020
Q4 | – | Sell |
-2,250,000
| Closed | -$125M | – | 2686 |
|
|
2020
Q3 | $125M | Buy |
+2,250,000
| New | +$125M | 0.01% | 595 |
|